Effect of coadministered ezetimibe and fenofibrate on the atherogenic dyslipidemia in obese patients with mixed hyperlipidemia

被引：0
|
作者：
Davies, M
Shah, A
Macdonell, G
Gumbiner, B
机构：
来源：
OBESITY RESEARCH | 2005年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A132 / A133
页数：2
相关论文
共 50 条
  • [41] EFFECTS OF A FIXED COMBINATION OF FENOFIBRATE AND PRAVASTATIN ON APOLIPOPROTEINS IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA
    Ducobu, J.
    Farnier, M.
    Fruchart, J. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 193 - 193
  • [42] Effect of Simvastatin Plus Inulin in Comparison with Simvastatin Plus Ezetimibe on the Treatment of Mixed Dyslipidemia
    Martinez-Abundis, Esperanza
    Barrera-Duran, Carmelita
    Gonzalez-Ortiz, Manuel
    Hernandez-Salazar, Eduardo
    GACETA MEDICA DE MEXICO, 2016, 152 : 88 - 95
  • [43] Effect of Simvastatin Plus Inulin vs. Simvastatin Plus Ezetimibe in Mixed Dyslipidemia
    Martinez-Abundis, Esperanza
    Barrera-Duran, Carmelita
    Gonzalez-Ortiz, Manuel
    Hernandez-Salazar, Eduardo
    DIABETES, 2010, 59 : A606 - A607
  • [44] VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
    Farnier, Michel
    Perevozskaya, Inna
    Taggart, William V.
    Kush, Debra
    Mitchel, Yale B.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (12) : 2641 - 2647
  • [45] TREATMENT WITH EZETIMIBE AND ORLISTAT OR RIMONABANT IN OVERWEIGHT/OBESE PATIENTS WITH DYSLIPIDEMIA AND A HISTORY OF STATIN-INTOLERANCE
    Florentin, M.
    Liberopoulos, E.
    Kostapanos, M.
    Nakou, E.
    Elisaf, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [46] Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe plus fenofibrate versus pravastatin monotherapy
    Grandi, Anna M.
    Nicolini, Eleonora
    Rizzi, Laura
    Caputo, Sara
    Annoni, Filippo
    Cremona, Anna M.
    Marchesi, Chiara
    Guasti, Luigina
    Maresca, Andrea M.
    Grossi, Paolo
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17
  • [47] Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia
    Tribble, Diane L.
    Farnier, Michel
    Macdonell, Geraldine
    Perevozskaya, Inna
    Davies, Michael J.
    Gumbiner, Barry
    Musliner, Thomas A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (06): : 796 - 801
  • [48] Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia
    Hisashi Adachi
    Hitoshi Nakano
    Kiichiro Yamamoto
    Masashi Nakata
    Hisatoshi Bekki
    Tomoki Honma
    Hideki Yoshiyama
    Masatoshi Nohara
    Lipids in Health and Disease, 14
  • [49] Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia
    Adachi, Hisashi
    Nakano, Hitoshi
    Yamamoto, Kiichiro
    Nakata, Masashi
    Bekki, Hisatoshi
    Honma, Tomoki
    Yoshiyama, Hideki
    Nohara, Masatoshi
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [50] Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia
    Okopien, B
    Krysiak, R
    Haberka, M
    Herman, ZS
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 45 (04) : 314 - 320
12345